ArticleAnnals of translational medicine2020

A new peg-filgrastim biosimilar, mecapegfilgrastim for primary prophylaxis of chemotherapy-related neutropenia is now available.

Umberto Tirelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.